The Actual Incidence of Congenital Adrenal Hyperplasia in Brazil May Not be as High as Inferred - An Estimate Based on a Public Neonatal Screening Program in the State of Goiás
- 1 January 2008
- journal article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 21 (5), 455-60
- https://doi.org/10.1515/jpem.2008.21.5.455
Abstract
The incidence of 21-hydroxylase deficiency (CYP21 D) congenital adrenal hyperplasia (CAH) in Brazil is purportedly one of the highest in the world (1:7,533). However, this information is not based on official data. The aim of this study was to determine the incidence of CYP21 D CAH in the state of Goiás, Brazil, based on the 2005 results of government-funded mandatory screening. Of the live births during this period, 92.95% were screened by heel-prick capillary 17alpha-hydroxyprogesterone (17-OHP). Of these, 82,343 were normal, 28 were at high risk for CAH and 232 at low risk for CAH. Eight cases, all from the high risk group, were confirmed. Eight asymptomatic children at 6-18 months of age still have high 17-OHP levels and await diagnostic definition. Based on the number of confirmed CYP21 D CAH cases among the 82,603 screened, the estimated annual incidence of the disease was 1:10,325, lower than the previously reported rate in Brazil.Keywords
This publication has 11 references indexed in Scilit:
- Aldosterone-to-Renin Ratio as a Marker for Disease Severity in 21-Hydroxylase Deficiency Congenital Adrenal HyperplasiaJournal of Clinical Endocrinology & Metabolism, 2007
- Congenital adrenal hyperplasiaThe Lancet, 2005
- High Reliability of Neonatal Screening for Congenital Adrenal Hyperplasia in SwitzerlandJournal of Clinical Endocrinology & Metabolism, 2002
- Lessons From 30 Years of Clinical Diagnosis and Treatment of Congenital Adrenal Hyperplasia in Five Middle European CountriesJournal of Clinical Endocrinology & Metabolism, 2001
- Procedure for Neonatal Screening for Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyHormone Research in Paediatrics, 2001
- Steroid disorders in children: Congenital adrenal hyperplasia and apparent mineralocorticoid excessProceedings of the National Academy of Sciences of the United States of America, 1999
- Genotyping Is a Valuable Diagnostic Complement to Neonatal Screening for Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase DeficiencyJournal of Clinical Endocrinology & Metabolism, 1999
- Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal HyperplasiaPEDIATRICS, 1998
- Steroid 21-hydroxylase deficiency: genotype may not predict phenotypeJournal of Clinical Endocrinology & Metabolism, 1995
- Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorderScreening, 1993